In the specialized field of immunology and viral resea LMP1 signaling leads to up-regulation of antiapoptotic proteins and provide growth signals in latently infected cells. Interacts with host UBE2I and rch, the LMP1 peptide serves as a cornerstone for investigators exploring the molecular mechanisms of the Epstein-Barr virus (EBV). As someone who has spent significant time evaluating various high-grade biochemical tools, I have found that the precision of these peptide products is paramount to achieving reproducible results in laboratory settings.
Understanding the Structural Integrity of LMP1 Peptide Pools
When sourcing materials EBV (LMP1) Peptide Pool for T cell assay LMP1 (156-164), derived from the the Epstein-Barr virus (EBV)-encoded oncogene latent membrane protein (LMP) 1, displays dual HLA restriction for HLA B57 s, I often prioritize the EBV (LMP1) Peptide pool. These are typically presented as a lyophilized mixture of 94 peptides, which ensures long-term stability and ease of reconstitution. Specifically, these pools often utilize 15-mer sequences with an 11-amino acid overlap, providing comprehensive coverage of the La High-purity EBV LMP1 peptide (159-167) for HLA-A*02:01 research. Key tool for studying CD8+ T cell reactivity against latent viral antigens. tent membrane protein 1 (LMP1) sequence.
From my experience, the quality of these peptides—specifically their purity—is critical for the stimulation of antigen-specific T cells. Whether performing ELISPOT, intracellular cytokine staining (ICS), or cytotoxicity assays, the inclusion of high-purity EBV LMP1 peptide variants ensures that the data reflects true biological activity rather than interference from truncated or misfolded sequences.
Scientific Context: LMP1 Signaling and Functionality
It is well-documented that LMP1 is a multifunctional membrane protein that orchestrates complex signaling cascades. In a research context, it is fascinating to observe how LMP1 signaling leads to up-regulation of antiapoptotic proteins and provides essential survival cues to latently infected cells.
For those focusing on epitope mapping, specific sequences like the LMP1 (156-164)—often referred to as the IAL peptide—are vital. These represent a 1 to 9 amino acid motif that displays dual HLA restri by R Khanna · 1998 · Cited by 231 — In the present report we used a novel protocol to identify CTL epitopes within LMP1 which can be recognized by both polyclonal and clonal CTL. Firstly, a ction. When working with these materials, researchers must keep in mind that Epstein-Barr virus LMP1 is consistently expressed in various models, making it a primary target for understanding immune surveillance.
Practical Considerations for Laboratory Research
When evaluating a Human EBV LMP1 peptide pool, I look for documentation regarding the strain of origin, most commonly the B95-8 strain. The following observations are key for any experimental design:
* Experimental Versatility: Whether you are using a lyophilized mixture of 26 peptides for control purposes or the full 94-peptide library, consistency in the peptide-to-buffer ratio is essential.
* Targeting Mechanisms: There is ongoing interest in identifying molecules that can selectively bind to LMP1. Some studies even explore phage-displayed libraries to find peptides that inhibit or tag these protei PepTivator EBV LMP1 is a pool of lyophilized peptides, consisting mainly of 15-mer sequences with 11 amino acids overlap. ns.
* Clinical Relevance: It is widely recognized that LMP1 is expressed in most EBV-associated lymphoproliferative diseases and malignancies. Consequently, tools that help track T cell reactivity are indispensable.
* Recent Discoveries: Emerging data suggests that EBV LMP1 increases the secretion of PD-L1 in larger EVs, which has opened new avenues f LMP1 signaling leads to up-regulation of antiapoptotic proteins and provide growth signals in latently infected cells. Interacts with host UBE2I and or studying immune evasion.
Personal Insight on Selection and Handling
In my own work, I have found that price points—ranging from approximately 36 to 58 units of currency depending on the specific catalog and purity grade—reflect the complexity of synthesis. Always verify the UniProt ID (such as P03230) to ensure the peptide sequence corresponds to your specific research model.
It is also worth noting that some compounds, such as LyP-1, are sometimes confused with LMP1 in literature; however, LyP-1 is distinct as it recognizes lymphatics and tumor cells in certain tumors. Always ensure your documentation specifies that the product is derived from the Epstein-Barr virus to avoid cross-reactivity issues.
By maintaining a rigorous standard for the reagents used, researchers can better interpret the nuanced inte EBV (LMP1) Peptide pool is a lyophilised mixture of 94 peptides from latent membrane protein 1 (LMP1) of Epstein-Barr virus (EBV; strain B95-8), and consists of ractions of latent membrane protein 1 (LMP1) within the cellular microenvironment. Whether your focus is on diagnostic assay development or fundamental virology, the reliability of your peptide source remains the foundation of your scientific progress.